Journal of Integrative Medicine2025，Vol.23Issue(1)：P.79-92,14.DOI:10.1016/j.joim.2024.11.003
Resveratrol promotes mitophagy via the MALAT1/miR-143-3p/RRM2 axis and suppresses cancer progression in hepatocellular carcinoma
Chun-yan Feng 1Cheng-song Cai 2Xiao-qian Shi 3Zhi-juan Zhang 4Dan Su 3Yun-qing Qiu4
作者信息
- 1. National Key Laboratory of Diagnosis and Treatment of Severe Infectious Disease,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,Zhejiang Provincial Key Laboratory for Drug Clinical Research and Evaluation,the First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310000,Zhejiang Province,China Department of Clinical Medicine,Hangzhou Medical College,Hangzhou 310053,Zhejiang Province,China
- 2. Department of Clinical Laboratory,the Affiliated Hospital of Hangzhou Normal University,Hangzhou 310015,Zhejiang Province,China
- 3. Department of Clinical Medicine,Hangzhou Medical College,Hangzhou 310053,Zhejiang Province,China
- 4. National Key Laboratory of Diagnosis and Treatment of Severe Infectious Disease,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,Zhejiang Provincial Key Laboratory for Drug Clinical Research and Evaluation,the First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310000,Zhejiang Province,China
- 折叠
摘要
关键词
Hepatocellular carcinoma/Resveratrol/Mitophagy/MALAT1/miR-143-3p分类
医药卫生引用本文复制引用
Chun-yan Feng,Cheng-song Cai,Xiao-qian Shi,Zhi-juan Zhang,Dan Su,Yun-qing Qiu..Resveratrol promotes mitophagy via the MALAT1/miR-143-3p/RRM2 axis and suppresses cancer progression in hepatocellular carcinoma[J].Journal of Integrative Medicine,2025,23(1):P.79-92,14.基金项目
supported by the Zhejiang Provincial Science and Technology Department Key Research and Development Plan(No.2020C03046). （No.2020C03046）
